Thus, FGFR signaling indirectly inhibits the expression of MHC Class I molecules by tumor cells through inhibition of the IFN-γ-mediated JAK/STAT signaling pathway and inhibits the expression of MHC Class II molecules in tumor cells on the other, thereby reducing T-cell infiltration and promoting immune escape. This evidence concerns the gene SOAT1 and neoplasm.